EU report provides basis for effective fight against development of resistant bacteria
EU agencies publish first integrated analysis of data from humans and animals
The use of certain antimicrobials in animals and humans is associated with resistance to these antimicrobials in bacteria from animals and humans. There are also important differences in the consumption of antimicrobials in animals and in humans between European countries. These are some of the findings of the first integrated analysis of data from humans, animals and food in Europe published jointly by the European Centre for Disease Prevention and Control (ECDC), the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA).
The ‘ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals’ also identifies data limitations that need to be addressed to allow further analysis and conclusions to be drawn. These include additional data on antimicrobial consumption by animal species, data on antimicrobial consumption in hospitals in more European countries and monitoring of resistant bacteria in the normal flora from both healthy and diseased people.
The analysis was carried out at the request of the European Commission and combines data from five European monitoring networks that gather information from the European Union (EU) Member States, Iceland, Norway and Switzerland.
This holistic approach aims to make better use of the existing data and strengthen coordinated surveillance systems on antimicrobial consumption and antimicrobial resistance in human and veterinary medicine, and to allow policy makers to decide on the best way to tackle antimicrobial resistance in humans and animals.
The joint report will inform the European Commission’s action plan against the rising threats from antimicrobial resistance. The data will also contribute to establishing strong methodologies and priorities in the fight against the development of antimicrobial resistance.
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Researchers discover ‘weak spot’ across major COVID-19 variants - "This study reveals a weak spot that is largely unchanged across variants and can be neutralized by an antibody fragment"
Category:VMAT_inhibitors
Ultrasound activates anticancer agent - New active substance unfold its cell-damaging effect only where it is supposed to
From Biopaste to Bioplastic - Forest scientists develop innovative wood-based materials for 3D printing
Study finds clear differences between organic and non-organic milk and meat
Nerve cells in the human brain can “count”
A bright spot for microbiological diagnostics - Researchers develop molecular probes to detect pathogens in clinical samples
Arachidic_acid
Less risk, less costs: Portable spectroscopy devices could soon become real - New approach to enable measurements without strong magnetic fields
Microbiologists improve taste of beer
Whole-body PET scan with new imaging agent can locate hidden blood clots
